Cancer Treatment Research in District of Columbia
Cancer Treatment Research (93.395) awarded $47.2 million to recipients in District of Columbia in 27 grants from fiscal 2021 to 2025, 0.9% of the program's national total. George Washington University (the) received the most, $32.1 million.
- Awarded in District of Columbia$47.2 million
- Awards27
- Share of the program0.9%
- Rank among states23rd of 50
- National total$5.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 16 | $10.4 million |
| FY 2022 | 16 | $10.5 million |
| FY 2023 | 11 | $8.7 million |
| FY 2024 | 10 | $8.4 million |
| FY 2025 | 12 | $9.2 million |
Recipients in District of Columbia
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| George Washington University (the) | Colleges and universities | 7 | $32.1 million |
| Georgetown University | Colleges and universities | 10 | $8.8 million |
| Children's Research Institute | Nonprofits | 7 | $5.1 million |
| Nanocan Therapeutics Corporation | Small businesses | 1 | $400,000 |
| Paz Pharmaceuticals LLC | Small businesses | 1 | $384,975 |
| Algometrx Inc | Small businesses | 1 | $372,996 |
Open opportunities under this program
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
- Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
See all 45 on the program page
Questions people ask
How much Cancer Treatment Research money goes to District of Columbia?
$47.2 million from fiscal 2021 to 2025, across 27 awards. District of Columbia ranks 23rd of 50 states and territories for this program.
Who receives Cancer Treatment Research money in District of Columbia?
The largest recipient is George Washington University (the), with $32.1 million in 7 awards. Next are Georgetown University and Children's Research Institute.
Can organizations in District of Columbia apply now?
Yes, 45 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Treatment Research in other states
Other large programs in District of Columbia
- National Railroad Passenger Corporation Grants
- Grants to States for Medicaid
- USAID Foreign Assistance for Programs Overseas
- Federal-State Partnership for Intercity Passenger Rail
- Greenhouse Gas Reduction Fund: National Clean Investment Fund
- Federal Transit Formula Grants
- International Programs to Support Democracy, Human Rights and Labor
- Environmental and Scientific Partnerships and Programs
- International Broadcasting Independent Grantee Organizations
- Highway Planning and Construction